Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Lynne Marie Sullivan, the CFO and Head of Corporate Development at Unity Biotechnology, Inc. (NASDAQ:UBX), recently sold shares of the company. According to a recent filing, Sullivan sold 153 shares ...

Anirvan Ghosh, the Chief Executive Officer of Unity Biotechnology, Inc. (NASDAQ:UBX), recently sold 642 shares of the company's common stock. The biotech company, currently valued at $38.42 million, ...

Belite Bio is a biotech firm specializing in innovative therapies for retinal degenerative eye diseases with high unmet needs ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 05, 2025. Let’s ...

We recently published a list of 15 Stocks That Took a Nosedive in January. In this article, we are going to take a look at where Viking Therapeutics, Inc.

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Oncolytics Biotech (ONCY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LOS ANGELES, CA / ACCESS Newswire / February 5, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

Low-cost passive index investing (in the S&P 500 or Nasdaq 100) has been key to impressive results in recent years. However, ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

MarketSmith India recommends these two stocks for Wednesday, 5 February.